University of Miami clinical trial pipeline

18 trials changed in the last 30 days: 1 stopped, 9 with notable changes, 8 with minor changes only.

1. Stopped

   PLEASURE (Pleasing Lovers, Efficacy, Arousal, Satisfaction, and…PLEASURE (Pleasing Lovers, Efficacy, Arousal, Satisfaction, and Uptake Research on Eroxon)

   Trial status changed: Not Yet Recruiting → Suspended

   University of Miami·Phase 4· NCT07636161· Registry history of NCT07636161 on ClinicalTrials.gov (opens the registry)

   Sep 28, 2026

2. Notable

   Lorigerlimab (MGD019) · Pancreatic Adenocarcinoma and Homologous…Lorigerlimab (MGD019) · Pancreatic Adenocarcinoma and Homologous Recombination Deficiency

   Primary and study completion pushed from Jun 1, 2031 to Jan 1, 2032

   University of Miami·Phase 2· NCT07565155· Registry history of NCT07565155 on ClinicalTrials.gov (opens the registry)

   Oct 13, 2026

3. Notable

   Utility of Multisensory Body-Representation in Spinal Cord Injury…Utility of Multisensory Body-Representation in Spinal Cord Injury (SCI) With Pain

   Primary and study completion pushed from Oct 20, 2026 to Oct 20, 2027

   University of Miami·Not applicable· NCT06010251· Registry history of NCT06010251 on ClinicalTrials.gov (opens the registry)

   Oct 15, 2026

4. Notable

   Exercise Program on Reaction Time and Mouse Accuracy in…Exercise Program on Reaction Time and Mouse Accuracy in Recreational Video Game Players

   Primary and study completion pushed from Jul 1, 2026 to May 1, 2027

   University of Miami·Not applicable· NCT06512675· Registry history of NCT06512675 on ClinicalTrials.gov (opens the registry)

   Oct 1, 2026

5. Notable

   Free-HER · Discontinuation of Maintenance HER-2 Directed Therapy…Free-HER · Discontinuation of Maintenance HER-2 Directed Therapy in Long-Term Survivors of Metastatic HER-2 Positive Breast Cancer

   Primary completion pushed from Jul 31, 2026 to Jul 31, 2027

   Also in this update: Enrollment closed, study ongoing; Study completion pushed from Jul 31, 2029 to Jul 31, 2030

   University of Miami·Not applicable· NCT05959291· Registry history of NCT05959291 on ClinicalTrials.gov (opens the registry)

   Sep 24, 2026

6. Notable

   CASE · Combating Alzheimer's Through Sleep and Exercise

   Primary endpoint(s) modified

   Also in this update: Enrollment increased: 30 → 60 participants; Interventions modified

   University of Miami·Not applicable· NCT04855630· Registry history of NCT04855630 on ClinicalTrials.gov (opens the registry)

   Sep 23, 2026

7. Notable

   PLAY2CONTROL Study

   Enrolling by invitation only

   Also in this update: Primary completion pushed from Oct 2027 to Dec 31, 2027; Study completion pushed from Oct 2027 to Jun 30, 2028

   University of Miami·Not applicable· NCT07556679· Registry history of NCT07556679 on ClinicalTrials.gov (opens the registry)

   Oct 16, 2026

8. Notable

   Auricular Vagus Nerve Stimulation Mechanisms for HIV-Associated…Auricular Vagus Nerve Stimulation Mechanisms for HIV-Associated Peripheral Neuropathy

   Recruitment opened

   University of Miami·Not applicable· NCT07822932· Registry history of NCT07822932 on ClinicalTrials.gov (opens the registry)

   Oct 6, 2026

9. Notable

   Velocity-Loss Training and Parkinson's Disease

   Recruitment opened

   Also in this update: Start date changed from estimate of Sep 23, 2026 to Sep 25, 2026

   University of Miami·Not applicable· NCT07840508· Registry history of NCT07840508 on ClinicalTrials.gov (opens the registry)

   Sep 28, 2026

10. Notable

    Tailored Anti-Inflammatory American Diet · Crohn's Disease

    Recruitment opened

    University of Miami·Not applicable· NCT07671872· Registry history of NCT07671872 on ClinicalTrials.gov (opens the registry)

    Sep 24, 2026

• Stopped: an ongoing trial was terminated, suspended or withdrawn.
• Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
• Minor: routine progress and housekeeping, such as sites added or enrollment closed.